Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
version: 4; Last updated: 2025-09-13 18:20:05+0000
url: https://fevir.net/resources/Evidence/397483
identifier: FEvIR Object Identifier/397483
name: Evidence_for_Results_for_Systolic_blood_pressure_at_12_weeks_in_GroupAssignment_Quadpill_vs_Candesartan
title: Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan
citeAs:
Evidence for Results for Systolic blood pressure at 12 weeks in GroupAssignment: Quadpill vs. Candesartan [Database Entry: FHIR Evidence Resource]. Contributors: Brian S. Alper, MD, MSPH [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 397483. Revised 2025-09-13. Available at: https://fevir.net/resources/Evidence/397483. Computable resource at: https://fevir.net/resources/Evidence/397483#json.
status: Active
author: Brian S. Alper, MD, MSPH:
publisher: Computable Publishing LLC
contact: support@computablepublishing.com
copyright:
https://creativecommons.org/licenses/by-nc-sa/4.0/
Type | Target[x] |
Part Of | Outcome Measure Report for QUARTET USA Trial |
description:
This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.
variableDefinition
variableRole: Population
observed: the study group
variableDefinition
variableRole: Exposure
variableDefinition
variableRole: Outcome
observed: Systolic blood pressure at 12 weeks
statistic
statisticType: difference in means
quantity: -4.5 mm Hg
SampleSizes
Extension NumberOfParticipants KnownDataCount 62 53 attributeEstimate
type: confidence interval
level: 0.95
range: -10.82-1.32 mm Hg
attributeEstimate
type: p-value
quantity: 0.123